Colour enhancement

From PsychonautWiki
(Redirected from Color enhancement)
Jump to navigation Jump to search

Colour enhancement is defined as an intensification of the brightness and vividness of colors in the external environment. During this experience, reds may seem “redder”, greens may seem “greener", and all colors will likely appear much more distinct, complex, and visually intense than they comparatively would be during everyday sober living.[1][2][3][4][5][6][7][8] At higher levels, this effect can sometimes result in seeing colours which are perceived as surreal or seemingly impossible.[3][4]

Colour enhancement is often accompanied by other coinciding effects such as acuity enhancement and pattern recognition enhancement.[1][2] It is most commonly induced under the influence of mild dosages of psychedelic compounds, such as LSD, psilocybin, and mescaline. However, it can also occur to a lesser extent under the influence of certain stimulants and dissociatives such as MDMA, ketamine[9], or 3-MeO-PCP.

Image examples

 Caption
2C-B-FLY
6-APB
25N-NBOMe
Proscaline
Experience:2.5g Syrian rue + 6g Mimosa Hostilis - Becoming God (my second experience with unity)
25C-NBOMe
Chameleon.jpgChameleon by Anonymous.
Experience:3-MeO-PCP - Extreme psychosis
5F-PB-22
Paradise island by Xanny.jpgParadise island by Subsentience
Experience:1mg 25c-NBOMe - Experiment in my room
LSA
Selective serotonin reuptake inhibitor
Enhancementofcolour.jpgShowing differences by Chelsea Morgan
2C-B
Experience:225mg Pregabalin +Cannabis -Bliss and Serenity; a hedonistic evening
Phenylpiracetam
DOI
4-AcO-MET
Experience:60mg 4-AcO-DMT Nonstop Quasi-Orgasmic Objectless Euphoria
5-MeO-DiPT
Experience:3 Grams of Mushrooms - Reset on my Life, Experiencing Satori and the Cosmic Perspective
4-HO-EPT
DOB
ETH-LAD
PARGY-LAD
4-HO-MPT
Psilocin
LSM-775
Experience:225ug LSD + 9g cubensis - Galactic Melt and the Meverse
Mescaline
Chur City in Switzerland.jpgChur, Switzerland by Naps284
Experience: 22mg 2C-B (oral) / 100ug 1P-LSD (sublingual) - My first time tripping alone (2 days in a row)
Psilocybin mushrooms
Ayahuasca
2C-D
Experience:A combination of DOC, 5-MAPB, 5-MeO-DMT, ETH-LAD, Cannabis, Pentedrone
Experience: 15mg 2C-B (oral) - A pleasant low-dose evening with Nexus
Experience:BK-2C-B - Various experiences
Bufotenin
MPT
25B-NBOMe
2C-I
EPT
LSZ
LSD
Pregabalin
25C-NBOH
Piracetam
THJ-018
AL-LAD
Tree.jpgJapanese Garden by Anonymous
2C-C
THJ-2201
Βk-2C-B
2C-T-2
Aniracetam
Experience:2C-P (approx. 35mg) - Asymmetrical Terror and the Geometric Sea
Experience:150mg MDMA + 20mg 2C-B - I designed it this way myself
4-HO-DET
TMA-6
2C-T-7
Experience:25mg 3-MeO-PCP - Enhanced film experience
Oxiracetam
1B-LSD
2C-E
JWH-018
Efavirenz
Experience:250mg DXM - DXM Itch and Trip Report
2C-P
Pramiracetam
Experience:800 seeds LSA - My First Trip Ever
4-AcO-DiPT
ALD-52
GABAergic hallucinogens
Experience:3.5g psilocybe cubensis - Relinquishing of Material Chains/Fear and Desolation
MDEA
Omberacetam
5-MeO-DALT
Experience:120mg - Garden of The Gods
5-MeO-MiPT
Experience:4x 200ug tabs - You do not need to understand
4-HO-DiPT
Bromo-DragonFLY
5-MeO-DiBF
Experience:40mg - Brothermind and the Forest's Hand
Experience:1000 Morning Glory seeds - Rediscovering the Self
DiPT
25D-NBOMe
Experience:3g mimosa / 3g syrian rue - Connecting with my body
Experience:300mg DXM + 25mg DMT + Cannabis - A crazy night
25I-NBOH
MiPT
6-APDB
Experience: 36mg 4-AcO-DiPT - Truly, one for the psychedelic animals among us
4-AcO-MiPT
MDA
Memantine
Methallylescaline
TMA-2
5-Hydroxytryptophan
Experience:Unknown dosage / 1 tab DOC - Psychedelia Turned Into Stimulant Psychosis
Experience:5.3g psilocybe cubensis - Dimensional Circumstance and the Fabric of Understanding
3-MeO-PCE
2C-T-21
Allylescaline
MDAI
Experience:Unknown Dose DOC (Insufflated) - Overdosing and Terifying Ego Death
4-HO-MET
Experience:4.5g - The Grand Introduction to Beauty and Fear
DET
Experience:Mushrooms and Snuff Films -- Trip Report (3.5 grams)
Experience:300µg AL-LAD - Don't worry, because you're everyone!
Experience: 5-EAPB (60mg) + 2-FMA (20mg) + 4-AcO-DMT (10mg) - Emotional catharsis
4-AcO-DMT
DOC
Cannabis
4-FA
DMT
4-AcO-DET
1P-ETH-LAD
Phenethylamine (compound)
Experience:300µg LSD - Togetherness and the Silent Dusk
Enhancement of colour rose.jpgRose by Chelsea Morgan
Escaline
Experience:25mg Deschloroketamine - My first time orally dosing DCK
PRO-LAD
3C-E
3-MMC
ΑMT
MiPLA
Experience:337mg DMT fumarate - A Day With DMT
Ibogaine
JWH-073
MDMA
25I-NBOMe
25B-NBOH
Enhancement of colours - woods.jpgThe Woods by Chelsea Morgan
Experience:4-HO-MiPT / A care free psychedelic getaway
4-HO-DPT
2C-H
1P-LSD
MET
Experience:75mg 3-FMA - Perfect Blend of Euphoria and Functionality
Experience:2 tabs DOB - My DOB Nightmare
DPT
4-HO-MiPT
Amanita muscaria

Psychoactive substances

Compounds within our psychoactive substance index which may cause this effect include:

... further results

Experience reports

Annectdotal reports which describe this effect with our experience index include:

See also

External links

References

  1. 1.0 1.1 Papoutsis, Ioannis; Nikolaou, Panagiota; Stefanidou, Maria; Spiliopoulou, Chara; Athanaselis, Sotiris (2014). "25B-NBOMe and its precursor 2C-B: modern trends and hidden dangers". Forensic Toxicology. 33 (1): 1–11. doi:10.1007/s11419-014-0242-9. ISSN 1860-8965. 
  2. 2.0 2.1 Bersani, Francesco Saverio; Corazza, Ornella; Albano, Gabriella; Valeriani, Giuseppe; Santacroce, Rita; Bolzan Mariotti Posocco, Flaminia; Cinosi, Eduardo; Simonato, Pierluigi; Martinotti, Giovanni; Bersani, Giuseppe; Schifano, Fabrizio (2014). "25C-NBOMe: Preliminary Data on Pharmacology, Psychoactive Effects, and Toxicity of a New Potent and Dangerous Hallucinogenic Drug". BioMed Research International. 2014: 1–6. doi:10.1155/2014/734749. ISSN 2314-6133. 
  3. 3.0 3.1 Hartman, Alan M.; Hollister, Leo E. (1963). "Effect of mescaline, lysergic acid diethylamide and psilocybin on color perception". Psychopharmacologia. 4 (6): 441–451. doi:10.1007/BF00403349. ISSN 0033-3158. 
  4. 4.0 4.1 Kleinman, J. E.; Gillin, J. C.; Wyatt, R. J. (1977). "A Comparison of the Phenomenology of Hallucinogens and Schizophrenia From Some Autobiographical Accounts*". Schizophrenia Bulletin. 3 (4): 560–586. doi:10.1093/schbul/3.4.560. ISSN 0586-7614. 
  5. . doi:10.3389/Ffnhum.2015.00346.  Missing or empty |title= (help)
  6. Obreshkova, D., Kandilarov, I., Angelova, V. T., Iliev, Y., Atanasov, P., & Fotev, P. S. (2017). PHARMACO-TOXICOLOGICAL ASPECTS AND ANALYSIS OF PHENYLALKYLAMINE AND INDOLYLALKYLAMINE HALLUCINOGENS (REVIEW). PHARMACIA, 64(1), 41-42. http://bsphs.org/wp-content/uploads/2017/04/Angelova.pdf
  7. Abraham, Henry David (1983). "Visual Phenomenology of the LSD Flashback". Archives of General Psychiatry. 40 (8): 884. doi:10.1001/archpsyc.1983.01790070074009. ISSN 0003-990X. 
  8. Baggott, M.J.; Coyle, J.R.; Erowid, E.; Erowid, F.; Robertson, L.C. (2011). "Abnormal visual experiences in individuals with histories of hallucinogen use: A web-based questionnaire". Drug and Alcohol Dependence. 114 (1): 61–67. doi:10.1016/j.drugalcdep.2010.09.006. ISSN 0376-8716. 
  9. Dillon, P (2003). "Patterns of use and harms associated with non-medical ketamine use". Drug and Alcohol Dependence. 69 (1): 23–28. doi:10.1016/S0376-8716(02)00243-0. ISSN 0376-8716.